Wellesse launches liquid Vitamin D3
Greg Andrews, vice president of marketing at Wellesse, said: “Liquid Vitamin D3 makes it easy for the entire family to reap the vitamin’s health benefits. Its great-tasting, fast-absorbing
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.
Ms Maneikis will be responsible for developing and leading Salient’s integrated human resources strategy to include talent acquisition, leadership development, total rewards and employee communications programs worldwide. Immediately